interferon alfa 2b

interferon alfa 2b

a water-soluble protein (MW 19,271) secreted by cells infected by virus; used to treat hairy cell leukemia, malignant melanoma, condylomata acuminata, AIDS-related Kaposi sarcoma, and chronic hepatitis C.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
In 2016, Amoytop Biotech launched Yshape pegylated interferon alfa 2b, the first China-made interferon drug with international patents.
rAd-IFN/Syn3 is built on adenoviral vector technology, a non-integrating vector, and results in enhanced expression of the therapeutic protein interferon alfa 2b. To date, it has completed three clinical trials in the US.
In 2012, noninvasive examinations showed no evidence of advanced fibrosis and the patient started the third treatment with pegylated interferon alfa 2b (1.5 [micro]g, subcutaneously, once a week), ribavirin (1.250 g per day, orally), and boceprevir (800 mg, orally, three times per day).
The objective was to see best response after first dose of interferon Alfa 2b.
Interferon alfa 2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C.
The third approved treatment for hepatitis B; others are interferon alfa 2b and Epivir (lamivudine).
In 2016, Amoytop Biotech launched Y-shape pegylated interferon alfa 2b, the first China-made interferon drug with international patents.